Weiss Multi-Strategy Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,040	Closed	-$294K	–	662
2018 Q3	$294K	Buy	11,040 +47	+0.4%	+$1.53K	0.01%	481
2018 Q2	$415K	Buy	10,993 +1,293	+13%	+$49.5K	0.01%	497
2018 Q1	$317K	Sell	9,700 -300	-3%	-$13.2K	0.01%	484
2017 Q4	$487K	Hold	10,000	–	–	0.01%	498
2017 Q3	$540K	Sell	10,000 -500	-5%	-$29.4K	0.02%	420
2017 Q2	$590K	Buy	+10,500	New	+$421K	0.02%	420

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PTLA Position: Q4 2018 in Review

Weiss Multi-Strategy Advisers sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 11,040 shares — an estimated $294K sold.

Weiss Multi-Strategy Advisers first reported a position in PTLA in Q2 2017 and held it in 6 quarters. The position peaked at $590K in Q2 2017. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

Weiss Multi-Strategy Advisers reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 11,040 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $294K.
Weiss Multi-Strategy Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Portola Pharmaceuticals, Inc. position peaked at $590K in Q2 2017.
181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.